Stock Market & Financial Investment News

News Breaks February 25, 2013 07:31 EDT ACT Actavis receives FDA approval for generic Suboxone Actavis announced that it has received approval from the FDA on its Abbreviated New Drug Application for Buprenorphine HCl and Naloxone HCl Dihydrate SL Tablets, 2 mg/0.5 mg and 8 mg/2 mg, the generic equivalent to Reckitt Benckiser Healthcare's Suboxone. Actavis intends to begin shipping the product immediately. Suboxone(R) is indicated for maintenance treatment of opioid dependence. For the 12 months ending December 31, 2012, Suboxone(R) tablets had total U.S. sales of approximately $625M, according to IMS Health data. News For ACT From The Last 14 Days Check below for free stories on ACT the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. 1 | 2 | all recent ACT news | >> May 17, 2013 14:48 EDT ACT Actavis may bid for Warner Chilcott to ward off takeover, Reuters says Subscribe for More Information 13:56 EDT ACT Actavis may purchase Warner Chilcott as takeover defense, Reuters reports Over past few weeks, Actavis (ACT) has "spurned approaches" from Valeant (VRX) and Mylan (MYL), and has instead pursued a bid for Warner Chilcott (WCRX), according to Reuters, citing people familiar with the situation. May 16, 2013 08:11 EDT ACT Novartis says no intention of pursuing Actavis, Bloomberg reports Subscribe for More Information 07:46 EDT ACT Jefferies sees high probability of Actavis, Warner Chilcott merger Jefferies believes a takeover of Warner Chilcott (WCRX) by Actavis (ACT) would make strategic and financial sense and would be significantly accretive to Actavis. The firm sees a high probability of a deal getting done and raised its price target for Actavis to $120 from $81 while keeping a Hold rating on the name. Jefferies estimates a deal at $24 per Warner Chilcott share would be accretive to Actavis' 2014 earnings by $5.31. May 15, 2013 19:37 EDT ACT Novartis weighing Actavis bid, WSJ reports Subscribe for More Information 18:17 EDT ACT Novartis weighs possible bid for Actavis, DJ reports Subscribe for More Information 07:03 EDT ACT Mylan highly unlikely to acquire Actavis, says Barclays Subscribe for More Information May 14, 2013 13:55 EDT ACT Actavis weighing over $5B bid for Warner Chilcott, snubbed Mylan, Bloomberg says Subscribe for More Information 13:36 EDT ACT Actavis discussing over $5B bid for Warner Chilcott, Bloomberg reports Bloomberg cites a source. 13:22 EDT ACT Actavis turned down $15B takeover bid from Mylan, Bloomberg reports Subscribe for More Information 07:18 EDT ACT BofA/Merrill to host a conference 2013 Health Care Conference is being held in Las Vegas on May 14-16. May 13, 2013 12:14 EDT ACT Actavis price target raised to $140 from $125 at Buckingham Subscribe for More Information 09:04 EDT ACT Actavis NDA for progestin-only patch accepted for filing by FDA Subscribe for More Information 09:00 EDT ACT Warner Chilcott price target raised to $21 from $18 at Susquehanna Susquehanna raised its price target on Warner Chilcott (WCRX) following its confirmation it is in discussions with Actavis (ACT) about a business combination. The firm believes the possible combination is compelling and worth exploring. Shares are Positive rated. 07:49 EDT ACT FDA decision on Opana a modest positive for Impax, says Leerink Leerink views the FDA's denial of Endo's (ENDP) Citizen Petition as a modest positive for Impax (IPXL), which it notes is the sole holder of 180 day exclusivity on generic Opana. However, Leerink says upside for Impax will be limited as Actavis (ACT), Sandoz, and Teva (TEVA) have settlements to enter the market starting in June 2013 when Impax's 180-day generic exclusivity expires. May 10, 2013 16:29 EDT ACT On The Fly: Closing Wrap Subscribe for More Information 15:06 EDT ACT Warner Chilcott resumes, up 24% after Actavis confirms merger talks 14:57 EDT ACT Actavis resumes trade, up 11% after confirming Warner Chilcott tie-up talks Subscribe for More Information 14:47 EDT ACT Warner Chilcott confirms in discussions with Actavis Subscribe for More Information 14:46 EDT ACT Actavis confirms early discussions with Warner Chilcott Subscribe for More Information 1 | 2 | all recent ACT news | >> Sign up for a free trial to see the rest of the stories you've been missing.